By John Lisack, Jr.
AAPS is thrilled to be returning to San Diego for our 2014 National Biotechnology Conference (NBC)!
The 2014 NBC will gather scientists from industry, government, and academia for three days of educational offerings specifically geared toward the biotechnology sector of the pharmaceutical sciences. This year, attendees will be able to attend one conference organized into four conference workstreams: biomanufacturing, biomarkers and pharmacokinetics/pharmacodynamics (PK/PD), research and discovery, and immunogenicity and administration routes. An integrated program will examine both theory and application from multiple perspectives including discovery, development, engineering, and regulatory aspects.
Programming this year will consist of a plenary session, 20 symposia, 6 roundtables, contributed paper poster presentations, four hot topics, and a late-breaking session. Additionally, an exposition hall will be hosting over 110 major companies featuring new technologies. There will also be job boards available highlighting new biotechnology career opportunities.
We are delighted that this year’s plenary program will feature presentations by a range of exemplary speakers:
- Kári Stefánsson, Ph.D., president, chairman, CEO, and cofounder of deCODE Genetics
- Victoria Hale, Ph.D., founder of Medicines 360, pharmaceutical scientist, and global health social entrepreneur
- Peter J. Schultz, Ph.D., professor, The Scripps Research Institute
And we are excited to premiere a new app for this meeting. Try the 2014 NBC app now to learn more about this year’s conference. Then use it on your mobile device to connect with meeting participants.